News
While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...
Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results